NCT00752908

Completed

Tissue Penetration of Antibiotics in Obesity

Washington University School of Medicine Source

Compare

Other study identifiers

Sponsor study identifier

070678

Study Type

observational

Actual enrollment (reported)

27

Locations

1 country

Sites

1

Timeline

Study Start

February 2008

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

June 2011

Actual (reported)

Study Completion

June 2011

Actual (reported)

Brief Summary

The purpose of this study is to evaluate cefoxitin pharmacokinetics in obese surgical patients.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 27 participants
Study completion date: June 2011
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
February 2008
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
September 12, 2008
Actual (reported)
First Posted
September 16, 2008
Actual (reported)
Primary Completion
June 2011
Actual (reported)
Study Completion
June 2011
Actual (reported)
Results Posted
September 9, 2019
Actual (reported)

Last Updated: September 9, 2019
Status Verified: September 2019
Results QC Date: September 5, 2019
Last Update Submitted: September 5, 2019

Conditions

Obesity

Outcome Measures

Primary Outcomes (1)

Cefoxitin Plasma Concentrations
Cefoxitin plasma concentrations
8 hours

Secondary Outcomes (1)

Cefoxitin Tissue Concentrations
8 hours

Study Arms (2)

Obese patients

Normal weight patients and volunteers

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

Surgical Patients at BJH

You may qualify if:

BMI \<25 and \>40

Sponsors & Collaborators

Washington University School of Medicine
Otherlead

Study Sites (1)

Barnes Jewish Hospital

St Louis, Missouri, 63110, United States

Biospecimen

Retention: SAMPLES WITHOUT DNA

plasma, interstitial fluid

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title: Evan Kharasch MD PhD
Organization: Washington University

Study Officials

Evan D Kharasch, MD, PhD
Washington University School of Medicine
PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee: Yes

Enrollment

27 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE CONTROL
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

September 12, 2008

First Posted

September 16, 2008

Study Start

February 2008

Date type not reported

This date has not been verified as actual or estimated.

NCT00783315

Evaluating Weight Loss Programs for Obese People at Risk for Heart Disease (The POWER Study)

Not ApplicableCompleted

NCT00146107

Weight Loss and Exercise in Obese, Physically Limited, Older Women and Men

Phase 3Completed

NCT01128400

Fat Perception in Humans (09-0873)

Completed

NCT01128829

Sugar-replacement Sweeteners, and Blood Sugar Control

Not ApplicableCompleted

NCT00782873

Balanced Propofol Sedation During Upper Endoscopy in Morbidly Obese Patients

Completed

NCT00603902

BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity Management

Phase 3Completed

Scheduled for elective abdominal or pelvic surgery

Surgical plan for intraoperative cefoxitin prophylaxis

Able to provide informed consent

You may not qualify if:

Allergy to Cefoxitin
Renal or Hepatic insufficiency

Contact the study team to confirm eligibility.

Primary Completion

June 2011

Actual (reported)

Study Completion

June 2011

Actual (reported)

Last Updated

September 9, 2019

Results First Posted

September 9, 2019

Record last verified: 2019-09

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00752908
Data provider: ClinicalTrials.gov
Source updated: 2019-09-09
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:31:10 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Results Posted

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

Obese patients

Normal weight patients and volunteers

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Results Point of Contact

Study Officials

Publication Agreements

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations